CompletedPhase 2

Curcumin and Vascular and Cognitive Function in Patients With Chronic Kidney Disease

United States94 participantsStarted 2018-06-01

Plain-language summary

The proposed research is clinical study evaluating the therapeutic benefits of curcumin on vascular function in patients with chronic kidney disease (CKD). The study aims to establish that curcumin will improve endothelial function and reduce large artery stiffness by reducing oxidative stress and in conjunction with lowering markers of inflammation and oxidative stress. In addition, the study will evaluate the potential benefit of curcumin on cognitive function in patients with CKD.

Who can participate

Age range

45 Years – 74 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * CKD stage IIIB and IV * BMI\<35 kg/m2 * Able to give informed consent Exclusion Criteria: * Consuming a diet rich in curcumin or taking curcumin supplements in the past 12 months * Life expectancy \<1 year * Pregnant, breastfeeding, or unwilling to use adequate birth control * Uncontrolled hypertension * Severe liver disease * Severe congestive heart failure * Hospitalization within the last 3 months * Active infection or antibiotic therapy * Immunosuppressive therapy within the last year

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Vascular Endothelial Function at 12 Months

Timeframe: 12 months

Trial details

NCT IDNCT03223883

SponsorDiana Jalal

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-01-25

Results submitted2024-07-26

View on ClinicalTrials.gov More Chronic Kidney Diseases trials